Skip to main content
. 2022 Dec 23;15(1):99. doi: 10.3390/cancers15010099

Table 1.

Baseline characteristics for patients receiving a blood transfusion or not during the perioperative period of curative resection for head and neck cancer.

Original Data After IPTW
No Transfusion
(n = 491)
Transfusion (n = 192) SDD No Transfusion
Transfusion SDD
Age 58 ± 13 57 ± 11 8.9 58 ± 12 57 ± 11 4.8
Sex, male 417 (84.9%) 172 (89.6%) 14.0 560 (86.8%) 434 (91.3%) 14.6
BMI, kg·m−2 25.0 ± 4.3 24.15 ± 3.68 21.6 24.87 ± 4.18 25.22 ± 3.93 8.5
ASA physical status > 3 112 (22.8%) 67 (34.9%) 26.9 179 (27.7%) 175 (36.9%) 19.8
Smoking 358 (72.9%) 151 (78.6%) 13.4 489 (75.8%) 396 (83.4%) 19.2
Betel nut chewing 237 (48.3%) 138 (71.9%) 49.7 354 (54.8%) 323 (68.1%) 27.5
Alcohol 293 (59.7%) 123 (64.1%) 9.0 397 (61.5%) 338 (71.1%) 20.3
Preoperative haemoglobin, g·dL−1 13.9 ± 1.6 13.1 ± 1.7 48.7 13.8 ± 1.7 13.5 ± 1.5 18.6
Anesthesia time, min * 8.15 ± 0.97 9.67 ± 0.71 178.4 8.49 ± 1.09 8.90 ± 1.14 36.8
Blood loss during surgery, mL * 5.60 ± 2.10 8.87 ± 1.48 179.9 6.33 ± 2.32 7.41 ± 2.15 48.5
Positive surgical margin 315 (64.2%) 113 (58.9%) 10.9 380 (58.8%) 244 (51.4%) 14.9
Primary tumour 117.6 15.1
T1 and T2 300 (61.1%) 27 (14.1%) 408 (63.3%) 265 (55.9%)
T3 and T4 191 (38.9%) 165 (85.9%) 237 (36.7%) 210 (44.1%)
Histologic differentiation 8.1 5.6
Well 213 (43.4%) 91 (47.4%) 305 (47.3%) 238 (50.1%)
Moderate to severe 278 (56.6%) 101 (52.6%) 340 (52.7%) 237 (49.9%)
Lymph node involvement 127 (25.9%) 99 (51.6%) 54.7 199 (30.8%) 183 (38.5%) 16.1
Adjunct radiotherapy 181 (36.9%) 136 (70.8%) 72.5 293 (45.4%) 228 (48.0%) 5.1
Adjunct chemotherapy 143 (29.1%) 125 (65.1%) 77.3 244 (37.9%) 207 (43.6%) 11.7

Values were mean ± SD or counts (percent). Standardized difference (SDD) is the difference in mean or proportion divided by the pooled standard error, expressed as a percentage; imbalance is defined as an absolute value greater than 20 (small effect size). IPTW: inverse probability treatment weighting; BMI: body mass index. * On a base-2 logarithmic scale.